Evolutionary Conservation of Vertebrate Blood-Brain Barrier Chemoprotective Mechanisms in Drosophila

Department of Anesthesia and Perioperative Care, San Francisco General Hospital, and Department of Pharmaceutical Chemistry, University of California at San Francisco, San Francisco, California 94143, USA.
The Journal of Neuroscience : The Official Journal of the Society for Neuroscience (Impact Factor: 6.75). 04/2009; 29(11):3538-50. DOI: 10.1523/JNEUROSCI.5564-08.2009
Source: PubMed

ABSTRACT Pharmacologic remedy of many brain diseases is difficult because of the powerful drug exclusion properties of the blood-brain barrier (BBB). Chemical isolation of the vertebrate brain is achieved through the highly integrated, anatomically compact and functionally overlapping chemical isolation processes of the BBB. These include functions that need to be coordinated between tight diffusion junctions and unidirectionally acting xenobiotic transporters. Understanding of many of these processes has been hampered, because they are not well mimicked by ex vivo models of the BBB and have been experimentally difficult and expensive to disentangle in intact rodent models. Here we show that the Drosophila melanogaster (Dm) humoral/CNS barrier conserves the xenobiotic exclusion properties found in the vertebrate vascular endothelium. We characterize a fly ATP binding cassette (ABC) transporter, Mdr65, that functions similarly to mammalian xenobiotic BBB transporters and show that varying its levels solely in the Dm BBB changes the inherent sensitivity of the barrier to cytotoxic pharmaceuticals. Furthermore, we demonstrate orthologous function between Mdr65 and vertebrate ABC transporters by rescuing chemical protection of the Dm brain with human MDR1/Pgp. These data indicate that the ancient origins of CNS chemoprotection extend to both conserved molecular means and functionally analogous anatomic spaces that together promote CNS selective drug partition. Thus, Dm presents an experimentally tractable system for analyzing physiological properties of the BBB in an intact organism.

  • Source
    • "mdr50 and the least effect was by mdr65, suggesting that mdr49 and mdr50 could be having a more direct role in polyQ-mediated pathogenesis. This can also be related to the functional differences between these genes (Mayer et al. 2009; Ricardo and Lehmann 2009). On comparing the observations , it was found that mdr65-RNAi background showed a significant decrease in mild phenotype just like mdr49-RNAi and mdr50-RNAi. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Trinucleotide CAG repeat disorders are caused by expansion of polyglutamine (polyQ) domains in certain proteins leading to fatal neurodegenerative disorders and are characterized by accumulation of inclusion bodies in the neurons. Clearance of these inclusion bodies holds the key to improve the disease phenotypes, which affects basic cellular processes such as transcription, protein degradation and cell signaling. In the present study, we show that P-glycoprotein (P-gp), originally identified as a causative agent of multidrug resistant cancer cells, plays an important role in ameliorating the disease phenotype. Using a Drosophila transgenic strain which expresses a stretch of 127-Glutamine repeats, we demonstrate that enhancing P-gp levels reduces eye degeneration caused by expression of polyQ, whereas reducing it increases the severity of the disease. Increase in polyQ inclusion bodies represses the expression of mdr genes, suggesting a functional link between P-gp and polyQ. P-gp up-regulation restores the defects in the actin organization and precise array of the neuronal connections caused by inclusion bodies. β-catenin homologue, Armadillo, also interacts with P-gp and regulates the accumulation of inclusion bodies. These results thus show that P-gp and polyQ interact with each other, and changing P-gp levels can directly affect neurodegeneration.
    Genetics 09/2013; 195(3). DOI:10.1534/genetics.113.155077 · 4.87 Impact Factor
  • Source
    • "In addition to the cell types shown above are the filopodia bearing perineurial glial cells at the edge of the carpet cell (4) and the glial cells found at the margin of the eye imaginal disc (5). et al., 2005; Stork et al., 2008; Mayer et al., 2009 "
    [Show abstract] [Hide abstract]
    ABSTRACT: The Drosophila compound eye comprises about 750 individual ommatidia arranged into an almost crystalline array. The eye is not needed for viability and thus served as a favorite model organ to decipher many signaling systems controlling diverse aspects such as cell fate allocation or cell-cycle control. Here, we review that the Drosophila eye can also serve to study the interaction between neurons and glial cells. In the Drosophila eye, all glial cells originate from the brain lobes and need to migrate onto the larval eye disc as neurogenesis is initiated during the third instar stage. Although we do have a relatively good understanding of the sequential progression of neurogenesis in the eye disc, we are still at the beginning in our dissection of the molecular pathways orchestrating the coordinated development of neurons and glial cells.
    Developmental Neurobiology 12/2011; 71(12):1310-6. DOI:10.1002/dneu.20893 · 4.19 Impact Factor
  • Source
    • "Genetic studies in Drosophila have greatly added to our understanding of the essential components of chemical barriers (Bellen et al. 1998; Schwabe et al. 2005; Stork et al. 2008; Tepass et al. 2001; Wu and Beitel 2004), but thus far most of these studies primarily have identified structurally essential genes for the development of polarized epithelia. Subtle modulators of the chemical barrier were discovered in adult organisms using behavior screens as in the case of the Moody GPCR (Bainton et al. 2005; Mayer et al. 2009). The above physiologic screen suggests that chemical, metabolic, and immune functions of surface glia are woven together in a remarkably diminutive interface and hints at analogous functions to vertebrate BBB cellular layers. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Central nervous system (CNS) physiology requires special chemical, metabolic, and cellular privileges for normal function, and blood-brain barrier (BBB) structures are the anatomic and physiologic constructs that arbitrate communication between the brain and body. In the vertebrate BBB, two primary cell types create CNS exclusion biology, a polarized vascular endothelium (VE), and a tightly associated single layer of astrocytic glia (AG). Examples of direct action by the BBB in CNS disease are constantly expanding, including key pathophysiologic roles in multiple sclerosis, stroke, and cancer. In addition, its role as a pharmacologic treatment obstacle to the brain is long standing; thus, molecular model systems that can parse BBB functions and understand the complex integration of sophisticated cellular anatomy and highly polarized chemical protection physiology are desperately needed. Compound barrier structures that use two primary cell types (i.e., functional bicellularity) are common to other humoral/CNS barrier structures. For example, invertebrates use two cell layers of glia, perineurial and subperineurial, to control chemical access to the brain, and analogous glial layers, fenestrated and pseudocartridge, to maintain the blood-eye barrier. In this article, we summarize our current understanding of brain-barrier glial anatomy in Drosophila, demonstrate the power of live imaging as a screening methodology for identifying physiologic characteristics of BBB glia, and compare the physiologies of Drosophila barrier layers to the VE/AG interface of vertebrates. We conclude that many unique BBB physiologies are conserved across phyla and suggest new methods for modeling CNS physiology and disease.
    Glia 09/2011; 59(9):1322-40. DOI:10.1002/glia.21147 · 6.03 Impact Factor
Show more


Available from